Patents - Global Data - Dimensions
UTILIZATION OF MICRO-RNA FOR DOWNREGULATION OF CYTOTOXIC TRANSGENE EXPRESSION BY MODIFIED VACCINIA VIRUS ANKARA (MVA)
Applicants:
- Bavarian Nordic (Denmark) [NORA names: Bavarian Nordic; Private Research; Denmark; Europe, EU; Nordic; OECD]
Abstract
The invention relates to a recombinant Modified Vaccinia Virus Ankara (MVA) comprising a series of miRNA target sequences arranged in a miRblock that is linked to a transgene, wherein each miRNA target sequence corresponds to a miRNA in a eukaryotic MVA producer cell. The present invention also relates to medical uses of the recombinant MVA.
Patent Family Records (6)
Utilization of microRNAs for downregulation of cytotoxic transgene expression by modified vaccinia virus Ankara (MVA).
BAVARIAN NORDIC A, Bavarian Nordic (Denmark) HAUSMANN JURGEN, KALLA MARKUS, SCHWENEKER MARC, (...more)
2024, KR-20240051214-A
UTILIZATION OF MICRO-RNA FOR DOWNREGULATION OF CYTOTOXIC TRANSGENE EXPRESSION BY MODIFIED VACCINIA VIRUS ANKARA (MVA)
BAVARIAN NORDIC AS, Bavarian Nordic (Denmark)
2024, IL-311078-A
Use of micrornas to down-regulate expression of modified vaccinia virus ankara (MVA) cytotoxic transgenes
Bavarian Nordic (Denmark), Bavarian Nordic AS HAUSMANN JUERGEN, M. Carla, M. Schwernek, (...more)
2024, CN-118234850-A
UTILIZATION OF MICRO-RNA FOR DOWNREGULATION OF CYTOTOXIC TRANSGENE EXPRESSION BY MODIFIED VACCINIA VIRUS ANKARA (MVA)
Bavarian Nordic (Denmark), Bavarian Nordic AS HAUSMANN JÜRGEN, KALLA MARKUS, SCHWENEKER MARC, (...more)
2024, AU-2022338199-A1
UTILIZATION OF MICRO-RNA FOR DOWNREGULATION OF CYTOTOXIC TRANSGENE EXPRESSION BY MODIFIED VACCINIA VIRUS ANKARA (MVA)
BAVARIAN NORDIC AS, Bavarian Nordic (Denmark) HAUSMANN JÜRGEN, KALLA MARKUS, SCHWENEKER MARC, (...more)
2023, WO-2023031428-A1
UTILIZATION OF MICRO-RNA FOR DOWNREGULATION OF CYTOTOXIC TRANSGENE EXPRESSION BY MODIFIED VACCINIA VIRUS ANKARA (MVA)
Bavarian Nordic (Denmark), Bavarian Nordic AS HAUSMANN JURGEN, KALLA MARKUS, SCHWENEKER MARC, (...more)
2023, CA-3230406-A1
